Manchester Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-88
Closed -$2.18K 1015
2023
Q3
$2.18K Hold
88
﹤0.01% 760
2023
Q2
$2.47K Hold
88
﹤0.01% 712
2023
Q1
$1.97K Sell
88
-16
-15% -$419 ﹤0.01% 792
2022
Q4
$2.76K Hold
104
﹤0.01% 639
2022
Q3
$3K Hold
104
﹤0.01% 566
2022
Q2
$2K Buy
+104
New +$1.95K ﹤0.01% 688

Other funds holding CCRN

Manchester Capital Management's CCRN Position: Q4 2023 in Review

Manchester Capital Management sold out of Cross Country Healthcare (CCRN) in Q4 2023, closing a stake of 88 shares — an estimated $2.18K sold.

Manchester Capital Management first reported a position in CCRN in Q2 2022 and held it in 6 quarters. The position peaked at $3K in Q3 2022. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2023.

  • Manchester Capital Management reported no remaining Cross Country Healthcare position as of Q4 2023 after selling out during the quarter.
  • Manchester Capital Management sold 88 Cross Country Healthcare shares in Q4 2023, an estimated $2.18K.
  • Manchester Capital Management first reported a position in Cross Country Healthcare in Q2 2022 and held it in 6 quarters.
  • Manchester Capital Management's Cross Country Healthcare position peaked at $3K in Q3 2022.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2023.

Based on Manchester Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.